First reported case of delayed‐type hypersensitivity reaction to non‐hyaluronic acid Polycaprolactone dermal filler following COVID‐19 vaccination: A case report and a review of the literature

Yasamin Kalantari; Afsaneh Sadeghzadeh‐Bazargan; Zeinab Aryanian; Parvaneh Hatami; Azadeh Goodarzi

doi:10.1002/ccr3.5343

Clinical Case Reports (Feb 2022)

First reported case of delayed‐type hypersensitivity reaction to non‐hyaluronic acid Polycaprolactone dermal filler following COVID‐19 vaccination: A case report and a review of the literature

Yasamin Kalantari,
Afsaneh Sadeghzadeh‐Bazargan,
Zeinab Aryanian,
Parvaneh Hatami,
Azadeh Goodarzi

Affiliations

Yasamin Kalantari: Department of Dermatology Razi Hospital Tehran University of Medical Sciences Tehran Iran
Afsaneh Sadeghzadeh‐Bazargan: Rasool Akram Medical Complex Clinical Research Development Center (RCRDC) School of Medicine Iran University of Medical Sciences Tehran Iran
Zeinab Aryanian: Autoimmune Bullous Diseases Research Center Tehran University of Medical Sciences Tehran Iran
Parvaneh Hatami: Autoimmune Bullous Diseases Research Center Tehran University of Medical Sciences Tehran Iran
Azadeh Goodarzi: Rasool Akram Medical Complex Clinical Research Development Center (RCRDC) School of Medicine Iran University of Medical Sciences Tehran Iran

DOI: https://doi.org/10.1002/ccr3.5343
Journal volume & issue: Vol. 10, no. 2
pp. n/a – n/a

Abstract

Read online

Abstract Cases of filler reactions after COVID‐19 vaccination have been reported. Here, we present the first case of delayed‐type reaction (DTR) to non‐hyaluronic acid Polycaprolactone dermal filler after the second dose of Sinopharm COVID‐19 vaccine which was improved with administration of topical and intralesional steroids.

Published in Clinical Case Reports

ISSN: 2050-0904 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: https://onlinelibrary.wiley.com/journal/20500904

About the journal

Abstract

Keywords